Articles

• Morbidity and CD4+ Cell Counts at Initial Presentation of a Cohort of HAART-Naive, HIV Positive Kenyan Patients: Implications to Initiating HAART

  AEO Otedo, CF Otieno, C Okai, D Othero, GO Oyoo, EO Omonge

  S3-S14

  • PDF
• CD4 + Cell Response to Anti-Retroviral Therapy (ARTS) In Routine Clinical Care Over One Year Period in a Cohort of HAART Naive, HIV Positive Kenyan Patients

  CF Otieno, AEO Otedo, D Othero, MY Otiende, P Okoth, EO Omonge, GO Oyoo

  S15-S24

  • PDF
• Cholangiopathy in a Co-Hort of HIV Positive Kenyan Patients

  AEO Otedo, JO Otieno, CF Otieno, GO Oyoo

  S25-S32

  • PDF
• Cryptococcus Meningitis in a Cohort of HIV Positive Kenyan Patients: Outcome after Two Weeks of Therapy

  AEO Otedo, CF Otieno, J Jowi, GO Oyoo, EO Omonge

  S33-S39

  • PDF
• Anti-Retroviral Therapy Related Liver Injury (ARLI): A Series of 11 Cases

  AEO Otedo, CF Otieno, GO Oyoo, EO Omonge

  S40-S47

  • PDF
• Pyomyositis in HIV: A Series of 12 Cases

  AEO Otedo, GO Oyoo, JO Otieno, CF Otieno, EO Omonge

  S48-S52

  • PDF
• Diabetes Mellitus/HIV Interphase: A Series of 10 Cases

  CF Otieno, AEO Otedo, GO Oyoo, E Omonge

  S53-S56

  • PDF
• Reasons for Change of Anti-Retroviral Therapy (ART) Drugs: Local Experience

  CF Otieno, AEO Otedo, MY Otiende, EO Omonge, GO Oyoo

  S57-S61

  • PDF
• HIV/TB Co-Infection:The Challenges

  JA Alouch

  S62-S67

  • PDF
• Tuberculosis/HIV Co-Infection

  JA Aluoch

  S68-S74

  • PDF
• Osteopaenia and Osteonecrosis in HIV Infection: Report of Two Cases

  EO Omonge, CF Otieno, MC Maritim, CS Ilovi, L Achieng, AEO Otedo

  S75-S78

  • PDF
• Unboosted Atazanavir in Treatment of HIV Infection: Consideration of Tolerability and Safety While Maintaining Efficacy– Report of Two Cases

  EO Omonge, CF Otieno, MC Maritim, CS Ilovi, L Achieng, AEO Otedo

  S79-S82

  • PDF
• Evolution of HIV Training for Enhanced Care Provision in Kenya: Challenges and Opportunities

  MC Maritim, CF Otieno, EO Omonge, GN Lule

  S83-S88

  • PDF